Pancreatic Cancer News
Antibiotics may prevent bacteria-mediated chemoresistance in patients with metastatic pancreatic cancer, a new study suggests.
Ulenistamab targets PAUF, a tumor-specific protein that is overexpressed in pancreatic cancer cells.
Adding ramucirumab to first-line chemotherapy does not improve outcomes in patients with advanced pancreatic ductal adenocarcinoma, a study suggests.
Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.
Overall compliance with eligibility criteria guidelines is low for pancreatic cancer trials, a recent study suggests.
In younger adults, there was a greater increase in the incidence of pancreatic cancer among women than among men.
People with type 2 diabetes have an increased risk of death from colorectal, pancreatic, liver, and endometrial cancer, compared with the general population.
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
NALIRIFOX outperformed treatment with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer in the NAPOLI-3 trial.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
New research suggests that, contrary to previous reports, dihydropyridine calcium channel blockers do not increase the risk of pancreatic cancer.
Extending adjuvant S-1 chemotherapy beyond 6 months after resection of pancreatic ductal adenocarcinoma does not improve outcomes, a real-world study suggests.
Project Renewal is an Oncology Center of Excellence initiative that aims to update the labeling information for certain older oncology drugs.
In a survey of more than 1000 adults, 83% said they are unaware of the signs or symptoms of pancreatic cancer.
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Bariatric surgery may reduce the risk of pancreatic cancer in patients with obesity who are younger than 50 years of age, a study suggests.
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Delivery of radiation to the celiac plexus can decrease pain and opioid use among patients with pancreatic cancer, a phase 2 study suggests.
A diagnosis of PCOS was associated with a 1.9-fold higher risk of pancreatic cancer in a case-control study.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.